Kathleen Orrico, PharmD

Title(s)Clinical Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
AddressPalo Alto Med Foundation
795 El Camino Real
Palo Alto CA 94301
ORCID ORCID Icon0000000194509040 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Michigan College of Pharmacy, Ann Arbor, MichiganDoctor of Pharmacy0601198Pharmacy
    University of California Berkeley, Berkeley, CaliforniaCertificate in Purchasing Mang0601199Purchasing
    Stanford Center for Professional Development, Stanford, CaliforniaCertificate in Genetics and Genomics082020Pharmacogenomics
    University of California, San Francisco07/2021Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UCSF School of Pharmacy2007  - 2013“Apples for Preceptors”
    UCSF School of Pharmacy2008  - 2008Long's Teaching Award
    UCSF School of Pharmacy2015  - 2015Long's Teaching Award
    UCSF2016  - 2019Advisor of the Year – Community Outreach Student Alliance

    Collapse Overview 
    Collapse Overview
    Kathleen B. Orrico, PharmD, BCPS is a Full Professor of Clinical Pharmacy at the University of California, San Francisco School of Pharmacy. Kathy is a graduate of the University of Michigan and holds a Certificate in Genetics and Genomics from the Stanford University Center for Professional Development. Her current mission is to translate gene-drug associations into clinical practice in order to improve medication safety and efficacy.

    Kathy also holds a Certificate in Purchasing Management from UC Berkeley, and is a Board Certified Pharmacotherapy Specialist. Over her 30 year career she has practiced as a Clinical Pharmacist with a focus on pharmacogenomics, drug safety surveillance, and medical group quality assurance. She has practiced as a pediatric hospital pharmacist, a drug education coordinator, and as a clinical operations manager.

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Basic concepts of cancer genetics and receptor tyrosine kinase inhibition for pharmacists. A narrative review. J Oncol Pharm Pract. 2023 Jul; 29(5):1187-1195. Orrico KB. PMID: 36734129; PMCID: PMC10302347.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    2. Basic Concepts in Genetics and Pharmacogenomics for Pharmacists. Drug Target Insights. 2019; 13:1177392819886875. Orrico KB. PMID: 31832012; PMCID: PMC6891005.
      View in: PubMed   Mentions: 2  
    3. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2016 Mar; 9(2):126-34. Romanelli RJ, Nolting L, Dolginsky M, Kym E, Orrico KB. PMID: 26812933.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    4. Comparison of Glucose Measures in Patients Receiving Concomitant Paroxetine and Pravastatin to Other SSRI/Statin Combinations. Ann Pharmacother. 2014 Sep; 48(9):1172-1176. Orrico KB, Huynh MH, Olson CW. PMID: 24928102.
      View in: PubMed   Mentions:    Fields:    
    5. Caring for visually impaired patients. J Am Pharm Assoc (2003). 2013 May-Jun; 53(3):e142-50. Orrico KB. PMID: 23699685.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    6. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting. J Manag Care Pharm. 2011 Nov; 17(9):695-700. Orrico KB, Wu M, Wilson AR. PMID: 22050394; PMCID: PMC10438021.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Clinical consequences of disseminating the rosiglitazone FDA safety warning. Am J Manag Care. 2010 May 01; 16(5):e111-6. Orrico KB, Lin JK, Wei A, Yue H. PMID: 20455636.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    8. Sources and types of discrepancies between electronic medical records and actual outpatient medication use. J Manag Care Pharm. 2008 Sep; 14(7):626-31. Orrico KB. PMID: 18774872; PMCID: PMC10437703.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    Kathleen's Networks
    Concepts (64)
    Derived automatically from this person's publications.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department